Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Health services and systems news

Show

From To
Activists United and Ignited by Urgency for HIV Prevention in Europe: EATG and AVAC call for the rollout of PrEP as a proven HIV prevention strategy

Initiated and organised entirely by the community of people living with and at risk for HIV, the second European HIV Prevention Summit brought together representatives of civil society, the pharmaceutical industry, researchers and academia in Brussels between 29 and 31 January. In addition to a thorough examination of PrEP (pre-exposure prophylaxis), the summit discussed the latest developments in the research fields of vaccines, rectal and vaginal microbicides and antibodies and their utility in HIV prevention.

Published
03 February 2016
From
EATG
High-level meeting on HIV/AIDS – how to get involved

This URGENT ACTION ALERT aims to inform civil society organizations on how to get involved in the high-level meeting on HIV/AIDS to be held during the UN General Assembly in New York in June 8 - 10 2016.

Published
02 February 2016
From
ICASO
Pfizer attempts to mislead public over research and development ‘facts’ with Tube ads

Ads by pharmaceutical company Pfizer on what it takes to bring a drug to market that have just been put up in London’s Westminster Tube station are misleading the public, and are explicitly attempting to influence Members of Parliament with targeted ads positioned by their exit to parliament.

Published
02 February 2016
From
MSF Access Campaign
European Medicines Agency Validates Gilead’s Type II Variation Application for Truvada for Reducing the Risk of Sexually Acquired HIV

Gilead Sciences announced today that the company’s Type II variation application for once-daily Truvada® (emtricitabine 200mg/tenofovir disoproxil fumarate 300mg) in combination with safer sex practices to reduce the risk of sexually acquired HIV-1 infection among uninfected adults at high risk, a strategy known as pre-exposure prophylaxis or PrEP, has been fully validated and is now under evaluation by the European Medicines Agency (EMA).

Published
01 February 2016
From
Gilead press release
Merck Throws a Wrench in Drug Pricing

Volume may help Merck make up what it loses on price. AbbVie and Gilead's drugs are priced so high that many governments and insurers will only pay for them for patients that have severe liver scarring, given HCV's slow progression. Zepatier is priced at a point that could make it affordable to treat a much larger population at earlier stages of the disease.

Published
01 February 2016
From
Bloomberg
New Merck combination pill Zepatier approved for hepatitis C treatment in the United States

Merck has received a US license for its direct-acting antiviral combination of grazoprevir and elbasvir, to be marketed as Zepatier. The combination of grazoprevir (an HCV protease inhibitor)

Published
01 February 2016
By
Keith Alcorn
Only 3 Presidential Candidates Share How They Will Address HIV

Only 3 out of the 16 candidates running for president answered GMHC's survey on how they plan to govern on issues concerning HIV.

Published
01 February 2016
From
HIVPlus
HIV is not transmitted under fully suppressive therapy: The Swiss Statement – eight years later

In summary, in the past eight years one randomised and two on-going observational trials continue to support the “no-risk” hypothesis of the Swiss statement, while the basis for the statement – the absence of observed cases – has further increased over time. Perhaps the most important legacy of the Swiss statement has been the empowerment of people living with HIV.

Published
30 January 2016
From
Swiss Medical Weekly
California Doles Out Millions to Insurers for Hepatitis C Drugs

In an unusual funding arrangement, California is paying private health plans hundreds of millions of dollars in supplemental payments to cover the high price of hepatitis C drugs for patients in Medi-Cal managed care plans.

Published
29 January 2016
From
KQED News
London sexual health clinics step up their support for people buying PrEP online

Several large sexual health clinics in London and Brighton have responded to the growing numbers of people importing PrEP medications from overseas by offering free safety monitoring

Published
29 January 2016
By
Roger Pebody

Filter by country